Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.K.
Biotech
Hookipa walks back Poolbeg purchase plan
After announcing acquisition plans at the beginning of 2025, Hookipa Pharma has pulled back its offer to buy Poolbeg Pharma.
Gabrielle Masson
Feb 20, 2025 1:34pm
UK regulator looks to halve approval times for low-risk trials
Oct 12, 2023 7:05am
EmVenio inks deal to operate 10 research mobile sites in UK
Jun 20, 2023 10:44am
Concept Life Sciences snapped up by investment group
Apr 4, 2023 3:10pm
